E0671 + rabeprazole sodium + E0671 placebo
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Stomach Ulcer
Conditions
Stomach Ulcer
Trial Timeline
Aug 1, 2005 → Apr 19, 2007
NCT ID
NCT00125736About E0671 + rabeprazole sodium + E0671 placebo
E0671 + rabeprazole sodium + E0671 placebo is a approved stage product being developed by Eisai for Stomach Ulcer. The current trial status is completed. This product is registered under clinical trial identifier NCT00125736. Target conditions include Stomach Ulcer.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00125736 | Approved | Completed |
Competing Products
20 competing products in Stomach Ulcer